Back

Prognostic significance of moderate primary mitral regurgitation and atrial fibrillation

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Mitral and tricuspid valve intervention Mitral Valve Regurgitation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Hideyuki Hayashi

Kitano Hospital, Osaka (Japan)

9 More presentations in this session

Presentation thumbnail
Clinical characteristics, natural history and predictors of disease progression in patients with degenerative mitral stenosis
Doctor N. Kuyama (Osaka, JP)
Abstract
Presentation thumbnail
The effect of a novel, user-friendly, transcatheter edge-to-edge mitral valve repair device in a porcine model of mitral regurgitation
Doctor C. Pan (Shanghai, CN)
Abstract
Presentation thumbnail
Transcatheter treatment of severe tricuspid regurgitation: first experiences with the edge-to-edge technique using the MitraClip
Professor S. Moebius-Winkler (Jena, DE)
Abstract
Presentation thumbnail
Tricuspid regurgitation in patients undergoing transcatheter aortic valve implantation
Doctor J. Shamekhi (Bonn, DE)
Abstract Slides
Presentation thumbnail
Ventricular arrhythmias in patients with mitral valve prolapse and severe mitral regurgitation
Miss A. Verstraeten-van Wijngaarden (Leiden, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Mitral and tricuspid valve intervention

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources